SOMAVAC® Receives Strong Reception at ASPS Annual Meeting

SOMAVAC Medical Solutions was thrilled to be in attendance at the American Society of Plastic Surgeons (ASPS) Annual Meeting, where our innovative approach to post-surgical recovery garnered significant attention. A special thanks to Alexei Mlodinow, CEO and CoFounder of SIA (sold to Integra LifeSciences), and long-time plastics guru Blaine Hamilton for their invaluable guidance during the event.

There was strong recognition at ASPS that seroma mitigation and elimination are essential to transforming outcomes for breast reconstruction patients. Attendees were particularly excited by SOMAVAC’s FDA-cleared technology, which not only improves clinical outcomes but also dramatically enhances the patient experience. By eliminating the need for patients to handle surgical fluid and allowing drains to be removed 30% sooner, SOMAVAC is reshaping the weeks-long recovery process that patients endure at home.

We’re proud of the overwhelming support and recognition at ASPS and are more committed than ever to revolutionizing the standard of care in post-surgical recovery. Stay tuned for more developments as we continue to advance patient-centered solutions!